What is Trialbee?
Founded in 2010 and headquartered in Malmö, Sweden, Trialbee operates at the intersection of life sciences and digital transformation. The company provides a sophisticated software ecosystem that optimizes the clinical trial process, facilitating seamless collaboration and data exchange among researchers, sponsors, and clinical sites. By addressing the inherent complexities of patient recruitment and trial management, Trialbee enables stakeholders to accelerate the delivery of life-saving therapies to market. Its platform serves as a centralized hub, reducing operational friction and enhancing the overall efficiency of the clinical research lifecycle.
How much funding has Trialbee raised?
Trialbee has raised a total of $20.3M across 3 funding rounds:
Unspecified
$3.3M
Series A
$5M
Other Financing Round
$12M
Unspecified (2013): $3.3M, investors not publicly disclosed
Series A (2015): $5M led by Industrifonden
Other Financing Round (2020): $12M supported by MTIP AG and Briban Invest AB
Key Investors in Trialbee
Industrifonden
Industrifonden is a Swedish venture capital fund that invests in unique, scalable innovations aimed at improving society through breakthrough technologies and science, with a specific focus on life sciences and deep tech.
MTIP AG
MTIP AG is a Swiss-based growth equity firm specializing in digital health investments, focusing on companies that leverage technology to improve patient outcomes and healthcare efficiency.
Briban Invest AB
Briban Invest AB is a private investment firm that provides strategic capital and operational support to growth-stage companies, often focusing on the Nordic technology and innovation ecosystem.
What's next for Trialbee?
With the recent infusion of capital, Trialbee is well-positioned to expand its market footprint and enhance its technological capabilities. The company is expected to focus on deepening its integration with global clinical trial networks and refining its data analytics features to provide more actionable insights for pharmaceutical sponsors. As the industry shifts toward decentralized and hybrid trial models, Trialbee's platform is increasingly relevant, offering the necessary digital infrastructure to support complex, multi-site research initiatives. Future strategic efforts will likely prioritize international market penetration and the development of advanced patient-centric tools to further streamline the clinical development pipeline.
See full Trialbee company page
